
{{header
 | title      = To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp. ( S1091 ; 113th Congress)
 | author     = [[]]
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 06
 | day        = 04
 | notes      = ''{{USBill|113|s|1091}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp. ( S1091 ; 113th Congress)
 | bill       = 1091
 | billtype   = s
 | purpose    = To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp.
 | wikipedia  =
}}

113 S1091 IS: To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp.U.S. Senate2013-06-04text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|S. 1091}}


{{Center|IN THE SENATE OF THE UNITED STATES}}


{{Center|June 4, 2013}}


{{Center|
[[w:|Ms. Mikulski]] introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on Homeland Security and Governmental Affairs|Committee on Homeland Security and Governmental Affairs]] }}


{{Center|A BILL}}

To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp.

={{anchor|H8B51D1DDC895430E92A2E36FEBBBCD08}}Section 1. Alzheimer's Disease Research Semipostal Stamp=



=={{anchor|H4C90181705DA4BC085738A72D8658F10}}(a) In general– ==

In order to afford a convenient way for members of the public to contribute to funding for medical research relating to Alzheimer's disease, the [[w:United States Postal Service|United States Postal Service]] shall issue a semipostal stamp (referred to in this Act as the“Alzheimer's Disease Research Semipostal Stamp”) in accordance with the provisions of this section.

=={{anchor|H4C83C2BE5FC444AAB3EA5A4875B35ADD}}(b) Terms and conditions– ==



==={{anchor|H6C65C70B63444C88AEC2C1E3D6B187E0}}(1) In general– ===

The issuance and sale of the Alzheimer's Disease Research Semipostal Stamp shall be governed by the provisions of[http://www.law.cornell.edu/uscode/text/39/416 [http://www.law.cornell.edu/uscode/text// section 416] of title 39, United States Code] , and regulations issued under such section, subject to the requirements of this subsection.

==={{anchor|H471D6F9902C34D66BCD5A5E3D80C012A}}(2) Duration– ===

The Alzheimer's Disease Research Semipostal Stamp shall be made available to the public for a period of 6 years, beginning no later than 12 months after the date of the enactment of this Act.

==={{anchor|H6157B90A3CEE4CB1AEF17CC249B8F280}}(3) Disposition of proceeds– ===

All amounts becoming available from the sale of the Alzheimer's Disease Research Semipostal Stamp (as determined under[http://www.law.cornell.edu/uscode/text/39/416 section 416(d) of such title 39] ) shall be transferred to the [[w:National Institutes of Health|National Institutes of Health]] , for the purpose described in subsection (a), through payments which shall be made at least twice a year.

=={{anchor|H6D1D866A4C3E4EADA440BA50A36DC84F}}(c) Definition– ==

For purposes of this Act, the term“semipostal stamp”refers to a stamp described in[http://www.law.cornell.edu/uscode/text/39/416 section 416(a)(1) of title 39, United States Code] .
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
